WASHINGTON, July 29, 2020 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will
release results for the second quarter 2020 on Wednesday, August 5, 2020, after the market
closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, August 5, 2020, during which
management will discuss the second quarter 2020 financial results
and other corporate activities. To participate in the conference
call, please dial 1-888-771-4371 (domestic) or 1-847-585-4405
(international) and use passcode 49854840.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-second-quarter-2020-financial-results-on-august-5-2020-301102555.html
SOURCE Vanda Pharmaceuticals Inc.